BusinessMDA Awards Human Clinical Trial Grant for Myotonic Dystrophy Natural History StudyBy Nasdaq OMXAug 30, 2017, 7:00 PM UTC
BusinessHemispherx Biopharma Repurposes Ampligen in Immuno-OncologyBy Nasdaq OMXMay 31, 2017, 4:04 PM UTC